No Detail Found!

Synthesis of Some New N-(Alkyl/aralkyl)-N-(2,3-dihydro-1,4- Benzodioxan-6-yl)-4-chlorobenzenesulfonamides as Possible Therapeutic Agents for Alzheimer's Disease and Type-2 Diabetes.

Author(s)
Muhammad Athar Abbasi Department of Chemistry, Government College University, Lahore, Pakistan
Sabahat Zahra Siddiqui Department of Chemistry, Government College University, Lahore, Pakistan
Noor ul Hadi Department of Chemistry, Government College University, Lahore, Pakistan
Ayesha Mumtaz Department of Chemistry, Government College University, Lahore, Pakistan
Syed Adnan Ali Shah Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia; Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Level 9, FF3, UniversitiTeknologi MARA, Puncak Alam Campus, Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia
Muhammad Ashraf Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Ghulam Hasan Abbasi Department of Soil Sciences, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Aziz-ur-Rehman Department of Chemistry, Government College University, Lahore, Pakistan
Abstract
In the current research work, a series of new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4chlorobenzenesulfonamides has been synthesized by reacting 1,4-benzozzdioxan-6-amine (1) with 4chlorobenzenesulfonyl chloride (2) to yield N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamide (3) which was further reacted with different alkyl/aralkyl halides (4a-n) to afford the target compounds (5a-n). Structures of the synthesized compounds were confirmed by IR, 1H-NMR, EI-MS spectral techniques and CHN analysis data. The results of enzyme inhibition showed that the molecules, N-2-phenethyl-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4chlorobenzenesulfonamide (5j) and N-(1-butyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-chlorobenzenesulfonamide (5d), exhibited moderate inhibitory potential against acetylcholinesterase with IC50 values 26.25±0.11 µM and 58.13±0.15 µM respectively, whereas, compounds N-benzyl-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-chlorobenzenesulfonamide (5i) and N-(pentane-2-yl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-chlorobenzenesulfonamide (5f) showed moderate inhibition against a-glucosidase enzyme as evident from IC50 values 74.52±0.07 and 83.52±0.08 µM respectively, relative to standards Eserine having IC50 value of 0.04±0.0001 µM for cholinesterases and Acarbose having IC50 value 38.25±0.12 µM for a-glucosidase, respectively. Fig. 1: Structure of Prontosil
Publication Details
Page(s) 61-68
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 32, Issue: 1, Year: 2019

Request the full text from PASTIC

Keywords
1H-NMR, enzyme inhibition, EI-MS, 4-chlorobenzenesulfonyl chloride, 4-Benzodioxan-6-amine, Alkyl/aralkyl halides
0

Citations

0

Downloads

58

Views